Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001558370-23-014524
Filing Date
2023-08-10
Accepted
2023-08-10 16:41:13
Documents
59
Period of Report
2023-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q gpcr-20230630x10q.htm   iXBRL 10-Q 2767968
2 EX-31.1 gpcr-20230630xex31d1.htm EX-31.1 15752
3 EX-31.2 gpcr-20230630xex31d2.htm EX-31.2 16036
4 EX-32.1 gpcr-20230630xex32d1.htm EX-32.1 9946
5 EX-32.2 gpcr-20230630xex32d2.htm EX-32.2 10233
6 GRAPHIC gpcr-20230630x10q001.jpg GRAPHIC 31575
  Complete submission text file 0001558370-23-014524.txt   8590075

Data Files

Seq Description Document Type Size
7 EX-101.SCH gpcr-20230630.xsd EX-101.SCH 42961
8 EX-101.CAL gpcr-20230630_cal.xml EX-101.CAL 43725
9 EX-101.DEF gpcr-20230630_def.xml EX-101.DEF 182187
10 EX-101.LAB gpcr-20230630_lab.xml EX-101.LAB 415440
11 EX-101.PRE gpcr-20230630_pre.xml EX-101.PRE 311806
53 EXTRACTED XBRL INSTANCE DOCUMENT gpcr-20230630x10q_htm.xml XML 1454075
Mailing Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080
Business Address 611 GATEWAY BLVD SUITE 223 SOUTH SAN FRANCISCO CA 94080 (628) 229-9277
Structure Therapeutics Inc. (Filer) CIK: 0001888886 (see all company filings)

EIN.: 981480821 | State of Incorp.: E9 | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-41608 | Film No.: 231160231
SIC: 2834 Pharmaceutical Preparations